more news from the Analyst Meeting:
Partnering talks in Japan are in late stages and should be announced ((soon)). Upfront fee like with Merck?
MRK holds the Vintafolide rights for Japan (Along with the World)
Sentiment: Strong Buy
It is just for the diagnostics - I would expect any upfront to be immaterial.